This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.86% per year. These returns cover a period from January 1, 1988 through February 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
medical-devices: Archive
Is it the Right Time to Add STERIS Stock to Your Portfolio?
by Zacks Equity Research
STE is buoyed by strong Healthcare and AST growth, solid margins and balance sheet strength, even as macro pressures and competition loom.
BSXNegative Net Change DGXNegative Net Change STENegative Net Change PAHCPositive Net Change
medical medical-devices
SLP Stock Crashes on Q1 Earnings Miss, Software Headwinds Hurt Sales
by Zacks Equity Research
Simulations Plus Q1 fiscal 2026 EPS miss as software revenue fall 17%, but services momentum and strong bookings support confidence for the rest of fiscal 2026.
CIENPositive Net Change SLPNegative Net Change GWRENegative Net Change BBPositive Net Change
computers earnings medical-devices smart-health tech-stocks
Should You Buy Electrolux AB (ELUXY) After Golden Cross?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
ELUXYNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Hims & Hers Plunges 39.2% in 3 Months: Time to Hold the Stock or Sell?
by Debanjana Dey
HIMS expands into Canada and the U.K. while revenue and subscribers grow. However, margins and execution raise concerns.
TDOCNegative Net Change HIMSNegative Net Change DOCSPositive Net Change
medical medical-devices
INGN Stock Gains Post Latest Launch to Expand Respiratory Care Suite
by Zacks Equity Research
Inogen launches Aurora CPAP masks to expand its respiratory care suite and enter the growing sleep apnea market.
BSXNegative Net Change CAHPositive Net Change IDXXPositive Net Change INGNNegative Net Change
medical medical-devices
Implied Volatility Surging for Accendra Health Stock Options
by Zacks Equity Research
Investors need to pay close attention to ACH stock based on the movements in the options market lately.
ACHPositive Net Change
medical medical-devices
Here's Why You Should Hold Avantor Stock in Your Portfolio for Now
by Zacks Equity Research
AVTR looks worth holding as its broad portfolio, strategic deals and cost savings offset Lab Solutions' weakness for now with AI tools and strong cash flow.
BSXNegative Net Change ISRGPositive Net Change MEDPPositive Net Change AVTRNegative Net Change
medical medical-devices
Is Boston Scientific Stock a Smart Pick for Your Portfolio Right Now?
by Zacks Equity Research
BSX is seeing solid international growth, MedSurg market-share gains and surging WATCHMAN sales, though macro and competition remain risks.
BSXNegative Net Change DGXNegative Net Change PAHCPositive Net Change BTSGPositive Net Change
medical medical-devices
Here's Why You Should Retain Cencora Stock in Your Portfolio Now
by Zacks Equity Research
Cencora's strength in U.S. Healthcare Solutions, along with rising specialty drug demand and biosimilar adoption, supports growth, though competitive pressures and international weakness remain headwinds.
BSXNegative Net Change ISRGPositive Net Change CORPositive Net Change MEDPPositive Net Change
medical medical-devices
Implied Volatility Surging for Guardian Pharmacy Services Stock Options
by Zacks Equity Research
Investors need to pay close attention to Guardian Pharmacy Services stock based on the movements in the options market lately.
GRDNPositive Net Change
medical medical-devices